Literature DB >> 9696815

The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons.

N Jarousse1, S Syan, C Martinat, M Brahic.   

Abstract

The strains of Theiler's murine encephalomyelitis virus, a picornavirus, are divided into two groups according to their neurovirulence after intracerebral inoculation. The highly virulent GDVII strain causes an acute, fatal encephalomyelitis, whereas the DA strain causes a mild encephalomyelitis followed by a chronic inflammatory demyelinating disease associated with viral persistence. Studies with recombinant viruses showed that the capsid plays the major role in determining these phenotypes. However, the molecular basis for the effect of the capsid on neurovirulence is still unknown. In this paper, we describe a large difference in the patterns of infection of primary neuron cultures by the GDVII and DA strains. Close to 90% of the neurons were infected 12 h after inoculation with the GDVII strain, and the cytopathic effect was complete 24 h postinoculation. In contrast, with the DA strain, viral antigens were not detected in neurons until 24 h postinoculation. Infected neurons accounted for only 2% of the total number of neurons, even 6 days after inoculation. No cytopathic effect was visible, and the cultures could be kept for the same length of time as the noninfected controls. Because the neurovirulence of the GDVII strain has been mapped to the capsid, we examined the role of the capsid in this difference of phenotype. We showed, using recombinant viruses, that the capsid was indeed responsible for the pattern of infection observed in vitro, most likely through its role in viral entry. Thus, the levels of neurovirulence of the GDVII and DA strains correlate with their abilities to infect cultured neurons, and this ability is controlled by the capsid.

Entities:  

Mesh:

Year:  1998        PMID: 9696815      PMCID: PMC109943     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.

Authors:  A Senkowski; B Shim; R P Roos
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

2.  The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.

Authors:  M Luo; K S Toth; L Zhou; A Pritchard; H L Lipton
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

3.  A single amino acid change determines persistence of a chimeric Theiler's virus.

Authors:  N Jarousse; R A Grant; J M Hogle; L Zhang; A Senkowski; R P Roos; T Michiels; M Brahic; A McAllister
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

4.  Theiler's virus genome is closely related to that of encephalomyocarditis virus, the prototype cardiovirus.

Authors:  S Ozden; F Tangy; M Chamorro; M Brahic
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Theiler's virus in brain cell cultures: lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages.

Authors:  M C Graves; L Bologa; L Siegel; H Londe
Journal:  J Neurosci Res       Date:  1986       Impact factor: 4.164

6.  Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus.

Authors:  M A Calenoff; K S Faaberg; H L Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Genetic mapping of the ability of Theiler's virus to persist and demyelinate.

Authors:  A McAllister; F Tangy; C Aubert; M Brahic
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Neurovirulence determinants of genetically engineered Theiler viruses.

Authors:  J L Fu; S Stein; L Rosenstein; T Bodwell; M Routbort; B L Semler; R P Roos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence.

Authors:  S B Stein; L Zhang; R P Roos
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Three-dimensional structure of Theiler virus.

Authors:  R A Grant; D J Filman; R S Fujinami; J P Icenogle; J M Hogle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more
  10 in total

1.  The GDVII strain of Theiler's virus spreads via axonal transport.

Authors:  C Martinat; N Jarousse; M C Prévost; M Brahic
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.

Authors:  K Jnaoui; T Michiels
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Theiler's virus infection of primary cultures of bone marrow-derived monocytes/macrophages.

Authors:  Cécile Martinat; Ignacio Mena; Michel Brahic
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Infection of macrophage primary cultures by persistent and nonpersistent strains of Theiler's virus: role of capsid and noncapsid viral determinants.

Authors:  Ignacio Mena; Jean-Pierre Roussarie; Michel Brahic
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  William J Karpus; Kevin J Kennedy; Brian T Fife; Jamie L Bennett; Mauro C Dal Canto; Steven L Kunkel; Nicholas W Lukacs
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

6.  Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.

Authors:  Eiichiro Kawai; Fumitaka Sato; Seiichi Omura; Nicholas E Martinez; Pratap C Reddy; Masaru Taniguchi; Ikuo Tsunoda
Journal:  J Neuroimmunol       Date:  2014-11-08       Impact factor: 3.478

7.  Enhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T Cells.

Authors:  Michael P Bell; Kevin D Pavelko
Journal:  Mol Cancer Ther       Date:  2016-01-28       Impact factor: 6.261

8.  The Pathogenesis of Saffold Virus in AG129 Mice and the Effects of Its Truncated L Protein in the Central Nervous System.

Authors:  Shawn Zheng Kai Tan; Kaw Bing Chua; Yishi Xu; Mookkan Prabakaran
Journal:  Viruses       Date:  2016-02-18       Impact factor: 5.048

9.  Immunohistochemical insights into Saffold virus infection of the brain of juvenile AG129 mice.

Authors:  Shawn Zheng Kai Tan; Mookkan Prabakaran
Journal:  Virol J       Date:  2016-11-25       Impact factor: 4.099

Review 10.  Saffold virus, an emerging human cardiovirus.

Authors:  Shawn Zheng Kai Tan; Mark Zheng Yi Tan; Mookkan Prabakaran
Journal:  Rev Med Virol       Date:  2016-10-10       Impact factor: 6.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.